mRNA vaccines — a new era in vaccinologyNorbert Pardi(University of Pennsylvania), Michael J. Hogan(University of Pennsylvania), Frederick Porter(Duke University), Drew Weissman(University of Pennsylvania)Nature Reviews Drug DiscoveryJanuary 12, 201810.1038/nrd.2017.243Cited by 4,452Open AccessFull TextSaveCiteExport RISWatch citationsAbstractRelated PapersmRNA-based therapeutics — developing a new class of drugsUğur Şahin, Katalin Karikó, Özlem Türeci|Nature Reviews Drug Discovery|2014|2.4kExpression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routesNorbert Pardi, Steven Tuyishime, Hiromi Muramatsu et al.|Journal of Controlled Release|2015|1kCodon Usage Influences the Local Rate of Translation Elongation to Regulate Co-translational Protein FoldingChien‐Hung Yu, Yunkun Dang, Zhipeng Zhou et al.|Molecular Cell|2015|679N1-methylpseudouridine-incorporated mRNA outperforms pseudouridine-incorporated mRNA by providing enhanced protein expression and reduced immunogenicity in mammalian cell lines and miceOliwia Andries, Séan Mc Cafferty, Stefaan C. De Smedt et al.|Journal of Controlled Release|2015|664Sequence-engineered mRNA Without Chemical Nucleoside Modifications Enables an Effective Protein Therapy in Large AnimalsAndreas Theß, Stefanie Grund, Barbara L. Mui et al.|Molecular Therapy|2015|508